Health Canada approves 2nd generic version of Ozempic — and it’s Canadian
TORONTO —
Health Canada has approved the second generic version of brand-name Ozempic, this one manufactured by Canadian company Apotex.
The authorization comes just three days after Health Canada approved the first generic semaglutide — the active ingredient in Novo Nordisk’s Ozempic — made by Dr. Reddy’s Laboratories in India.
The injectable medications are approved for the treatment of Type 2 diabetes in adults, but Ozempic is often prescribed off-label for weight loss.


